Review
[Nebivolol: a beta blocker with vasodilator properties]
[Article in
French]
Affiliations
- PMID: 10804847
Item in Clipboard
Review
[Nebivolol: a beta blocker with vasodilator properties]
[Article in
French]
Praxis (Bern 1994).
.
Abstract
Nebivolol is a new cardioselective beta-blocking agent possessing vasodilatory properties involving the endothelium. This compound is a dl-racemic mixture. The d-enantiomer is responsible for the beta-blocking properties whereas the l-enantiomer induces a vasodilation via a nitric oxide (NO) mechanism. Nebivolol is an unique agent that appears promising for the management of patients with hypertension, coronary heart disease or congestive heart failure.
Similar articles
-
Nitric oxide mechanisms of nebivolol.Ther Adv Cardiovasc Dis. 2009 Aug;3(4):317-27. doi: 10.1177/1753944709104496. Epub 2009 May 14. Ther Adv Cardiovasc Dis. 2009. PMID: 19443516 Review.
-
Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.J Am Coll Cardiol. 2009 Apr 28;53(17):1532-8. doi: 10.1016/j.jacc.2008.11.057. J Am Coll Cardiol. 2009. PMID: 19389564
-
Nebivolol: new therapy update.Cardiol Rev. 2006 Sep-Oct;14(5):259-64. doi: 10.1097/01.crd.0000223651.03023.8e. Cardiol Rev. 2006. PMID: 16924166 Review.
-
Nebivolol: the somewhat-different beta-adrenergic receptor blocker.J Am Coll Cardiol. 2009 Oct 13;54(16):1491-9. doi: 10.1016/j.jacc.2009.05.066. J Am Coll Cardiol. 2009. PMID: 19815121 Review.
-
The role of the new beta-blockers in treating cardiovascular disease.Am J Hypertens. 2005 Dec;18(12 Pt 2):169S-176S. doi: 10.1016/j.amjhyper.2005.09.009. Am J Hypertens. 2005. PMID: 16373195 Review.
Cited by
-
Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.Br J Pharmacol. 2006 Apr;147(7):699-706. doi: 10.1038/sj.bjp.0706648. Br J Pharmacol. 2006. PMID: 16474420 Free PMC article.